ACRV Financial Statements

Balance sheet, income statement, cash flow, and dividends for Acrivon Therapeutics Inc (ACRV).


$187.44M Market Cap.

As of 03/28/2025 5:00 PM ET (MRY) • Disclaimer

ACRV Market Cap. (MRY)


ACRV Shares Outstanding (MRY)


ACRV Assets (MRY)


Total Assets

$196.59M

Total Liabilities

$19.80M

Total Investments

$144.75M

ACRV Income (MRY)


Revenue

$0

Net Income

-$80.56M

Operating Expense

$89.20M

ACRV Cash Flow (MRY)


CF Operations

-$65.67M

CF Investing

-$51.77M

CF Financing

$121.03M

ACRV Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

-

0%

0%

-

2020

$0

-

-

0%

-

ACRV Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$196,588,000 (42.18%)

$138,265,000 (-23.71%)

$181,226,000 (70.03%)

$106,587,000 (4778.12%)

Assets Current

$181,629,000 (40.05%)

$129,692,000 (-1.82%)

$132,095,000 (31.56%)

$100,408,000 (5741.07%)

Assets Non-Current

$14,959,000 (74.49%)

$8,573,000 (-82.55%)

$49,131,000 (695.13%)

$6,179,000 (1225.97%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$176,786,000 (45.87%)

$121,195,000 (-28.91%)

$170,475,000 (816.01%)

-$23,809,000 (-183.00%)

Property Plant & Equipment Net

$8,025,000 (1.48%)

$7,908,000 (15.24%)

$6,862,000 (18.49%)

$5,791,000 (9715.25%)

Cash & Equivalents

$40,016,000 (9.85%)

$36,429,000 (21.81%)

$29,907,000 (-70.09%)

$99,991,000 (4924.67%)

Accumulated Other Comprehensive Income

$447,000 (638.55%)

-$83,000 (12.63%)

-$95,000 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$144,751,000 (58.30%)

$91,443,000 (-34.74%)

$140,113,000 (0%)

$0 (0%)

Investments Current

$139,662,000 (52.73%)

$91,443,000 (-6.91%)

$98,232,000 (0%)

$0 (0%)

Investments Non-Current

$5,089,000 (0%)

$0 (0%)

$41,881,000 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$758,000 (-84.98%)

$5,048,000 (458.41%)

$904,000 (-6.22%)

$964,000 (608.82%)

Accumulated Retained Earnings (Deficit)

-$196,976,000 (-69.19%)

-$116,420,000 (-107.77%)

-$56,032,000 (-125.34%)

-$24,865,000 (-188.39%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$3,645,000 (-21.51%)

$4,644,000 (-6.39%)

$4,961,000 (-11.85%)

$5,628,000 (0%)

Debt Current

$1,057,000 (20.52%)

$877,000 (20.80%)

$726,000 (9.34%)

$664,000 (0%)

Debt Non-Current

$2,588,000 (-31.30%)

$3,767,000 (-11.05%)

$4,235,000 (-14.69%)

$4,964,000 (0%)

Total Liabilities

$19,802,000 (16.00%)

$17,070,000 (58.78%)

$10,751,000 (36.47%)

$7,878,000 (746.19%)

Liabilities Current

$17,214,000 (29.40%)

$13,303,000 (104.16%)

$6,516,000 (123.61%)

$2,914,000 (375.37%)

Liabilities Non-Current

$2,588,000 (-31.30%)

$3,767,000 (-11.05%)

$4,235,000 (-14.69%)

$4,964,000 (1461.01%)

ACRV Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$25,207,000 (19.58%)

$21,079,000 (142.06%)

$8,708,000 (253.12%)

$2,466,000 (89.98%)

Research & Development Expense

$63,992,000 (39.04%)

$46,024,000 (92.18%)

$23,949,000 (74.58%)

$13,718,000 (633.58%)

Operating Expenses

$89,199,000 (32.93%)

$67,103,000 (105.48%)

$32,657,000 (101.79%)

$16,184,000 (410.86%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$80,556,000 (-33.40%)

-$60,388,000 (-93.76%)

-$31,167,000 (-91.88%)

-$16,243,000 (-206.13%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$80,556,000 (-33.40%)

-$60,388,000 (-93.76%)

-$31,167,000 (-91.88%)

-$16,243,000 (-206.13%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$80,556,000 (-33.40%)

-$60,388,000 (-93.76%)

-$31,167,000 (-91.88%)

-$16,243,000 (-206.13%)

Weighted Average Shares

$33,791,817 (53.06%)

$22,078,190 (435.63%)

$4,121,912 (136.43%)

$1,743,382 (21.70%)

Weighted Average Shares Diluted

$33,791,817 (53.06%)

$22,078,190 (435.63%)

$4,121,912 (136.43%)

$1,743,382 (21.70%)

Earning Before Interest & Taxes (EBIT)

-$80,556,000 (-33.40%)

-$60,388,000 (-93.76%)

-$31,167,000 (-91.88%)

-$16,243,000 (-206.13%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$89,199,000 (-32.93%)

-$67,103,000 (-105.48%)

-$32,657,000 (-101.79%)

-$16,184,000 (-410.86%)

ACRV Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$51,771,000 (-202.08%)

$50,717,000 (135.80%)

-$141,676,000 (-59427.73%)

-$238,000 (-1486.67%)

Net Cash Flow from Financing

$121,027,000 (7888.10%)

-$1,554,000 (-101.53%)

$101,709,000 (-9.37%)

$112,221,000 (3784.42%)

Net Cash Flow from Operations

-$65,669,000 (-54.00%)

-$42,641,000 (-41.58%)

-$30,117,000 (-115.40%)

-$13,982,000 (-398.82%)

Net Cash Flow / Change in Cash & Cash Equivalents

$3,587,000 (-45.00%)

$6,522,000 (109.31%)

-$70,084,000 (-171.51%)

$98,001,000 (137929.58%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$49,003,000 (-194.23%)

$52,005,000 (137.28%)

-$139,510,000 (0%)

$0 (0%)

Capital Expenditure

-$2,768,000 (-114.91%)

-$1,288,000 (40.54%)

-$2,166,000 (-810.08%)

-$238,000 (-1486.67%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$130,090,000 (16685.81%)

$775,000 (-99.24%)

$101,709,000 (10170800.00%)

$1,000 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$14,288,000 (22.98%)

$11,618,000 (431.72%)

$2,185,000 (339.64%)

$497,000 (16466.67%)

Depreciation Amortization & Accretion

$1,938,000 (47.49%)

$1,314,000 (20.00%)

$1,095,000 (31.61%)

$832,000 (6300.00%)

ACRV Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-46.20% (-8.71%)

-42.50% (0.00%)

-42.50% (-142.16%)

100.80%

Return on Average Assets (ROAA)

-42.30% (-8.46%)

-39.00% (-79.72%)

-21.70% (27.42%)

-29.90%

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-56.40% (-9.73%)

-51.40% (-31.12%)

-39.20% (89.27%)

-365.30%

Dividend Yield

0% (0%)

0% (0%)

0%

-

Price to Earnings Ratio (P/E)

-2.53 (-40.81%)

-1.8 (-17.85%)

-1.52

-

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

1.06 (17.65%)

0.9 (-36.14%)

1.41

-

Debt to Equity Ratio (D/E)

0.11 (-20.57%)

0.14 (123.81%)

0.06 (119.03%)

-0.33 (-198.20%)

Earnings Per Share (EPS)

-2.38 (13.14%)

-2.74 (63.76%)

-7.56 (18.88%)

-9.32 (-151.89%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-2.02 (-1.76%)

-1.99 (74.59%)

-7.83 (3.98%)

-8.16 (-314.69%)

Book Value Per Share (BVPS)

5.23 (-4.68%)

5.49 (-86.73%)

41.36 (402.83%)

-13.66 (-132.54%)

Tangible Assets Book Value Per Share (TABVPS)

5.82 (-7.11%)

6.26 (-85.75%)

43.97 (-28.09%)

61.14 (3909.05%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (-100.00%)

-1 (85.71%)

-7

-

Enterprise Value Over EBITDA (EV/EBITDA)

-1.88 (-33.31%)

-1.41 (80.10%)

-7.09

-

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0

Current Ratio

10.55 (8.23%)

9.75 (-51.91%)

20.27 (-41.17%)

34.46 (1128.85%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$68,437,000 (-55.79%)

-$43,929,000 (-36.07%)

-$32,283,000 (-127.03%)

-$14,220,000 (-404.61%)

Enterprise Value (EV)

$147,842,502 (77.38%)

$83,345,990 (-60.92%)

$213,262,610

-

Earnings Before Tax (EBT)

-$80,556,000 (-33.40%)

-$60,388,000 (-93.76%)

-$31,167,000 (-91.88%)

-$16,243,000 (-206.13%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$78,618,000 (-33.08%)

-$59,074,000 (-96.44%)

-$30,072,000 (-95.13%)

-$15,411,000 (-191.16%)

Invested Capital

$143,003,000 (53.47%)

$93,177,000 (-37.78%)

$149,764,000 (1508.64%)

$9,310,000 (2327.27%)

Working Capital

$164,415,000 (41.26%)

$116,389,000 (-7.32%)

$125,579,000 (28.81%)

$97,494,000 (8715.01%)

Tangible Asset Value

$196,588,000 (42.18%)

$138,265,000 (-23.71%)

$181,226,000 (70.03%)

$106,587,000 (4778.12%)

Market Capitalization

$187,440,502 (71.66%)

$109,195,990 (-54.61%)

$240,593,610

-

Average Equity

$174,428,750 (22.62%)

$142,249,250 (93.98%)

$73,333,000 (555.17%)

-$16,111,000

Average Assets

$190,594,500 (23.04%)

$154,900,750 (7.64%)

$143,906,500 (164.60%)

$54,386,000

Invested Capital Average

$142,816,500 (21.62%)

$117,423,750 (47.63%)

$79,537,000 (1688.96%)

$4,446,000

Shares

31,136,296 (40.29%)

22,194,307 (6.27%)

20,884,862 (11.03%)

18,809,823